| 000 | 01596 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515122038.0 | ||
| 264 | 0 | _c20081204 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1432-5233 | ||
| 024 | 7 |
_a10.1007/s00592-008-0036-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerraccioli, GianFranco | |
| 245 | 0 | 0 |
_aB cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids. _h[electronic resource] |
| 260 |
_bActa diabetologica _cSep 2008 |
||
| 300 |
_a195-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aB-Lymphocytes _xpathology |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xcomplications |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLeukapheresis _xmethods |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGremese, Elisa | |
| 700 | 1 | _aDe Santis, Maria | |
| 773 | 0 |
_tActa diabetologica _gvol. 45 _gno. 3 _gp. 195-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00592-008-0036-9 _zAvailable from publisher's website |
| 999 |
_c17994048 _d17994048 |
||